08/04/2025
7:51 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/04/2025
7:33 AM | Praxis Precision Medicines (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/17/2025
7:02 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2025
3:47 PM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2025
11:00 AM | JANUS HENDERSON GROUP PLC (Filed by)
Praxis Precision Medicines (Subject)
| Form SCHEDULE 13G/A | |
05/15/2025
4:45 PM | Praxis Precision Medicines (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
05/15/2025
2:01 PM | Cormorant Asset Management, LP (Filed by)
Praxis Precision Medicines (Subject)
| Form SCHEDULE 13G/A | |
05/14/2025
10:47 AM | JANUS HENDERSON GROUP PLC (Filed by)
Praxis Precision Medicines (Subject)
| Form SCHEDULE 13G | |
05/13/2025
10:32 AM | Capital Research Global Investors (Filed by)
Praxis Precision Medicines (Subject)
| Form SCHEDULE 13G/A | |
05/12/2025
8:05 AM | Adage Capital Management, L.P. (Filed by)
Praxis Precision Medicines (Subject)
| Form SCHEDULE 13G | |
05/02/2025
4:12 PM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for PRAX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Praxis Precision Medicines and its competitors with MarketBeat's FREE daily newsletter. |
05/02/2025
7:35 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2025
7:38 AM | Praxis Precision Medicines (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/19/2025
4:00 PM | Praxis Precision Medicines (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
| Form SCHEDULE 13G | |
02/28/2025
7:50 AM | Praxis Precision Medicines (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/28/2025
7:52 AM | Praxis Precision Medicines (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/28/2025
7:03 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2025
7:06 AM | Praxis Precision Medicines (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2025
5:08 PM | Praxis Precision Medicines (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
3:29 PM | Mastrocola Lauren (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
3:29 PM | Nemiroff Alex (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
2:03 PM | Cormorant Asset Management, LP (Filed by)
Praxis Precision Medicines (Subject)
| Form SCHEDULE 13G/A | |
02/05/2025
9:10 AM | MORGAN STANLEY (Filed by)
Praxis Precision Medicines (Subject)
| Form SCHEDULE 13G | |
01/29/2025
4:20 PM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/14/2025
5:50 PM | Nemiroff Alex (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
5:50 PM | Kelly Timothy Edwin (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
5:50 PM | Praxis Precision Medicines (Issuer)
Souza Marcio (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
5:51 PM | Mastrocola Lauren (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
6:50 PM | Kelly Timothy Edwin (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
6:50 PM | Nemiroff Alex (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
6:50 PM | Mastrocola Lauren (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
6:50 PM | Praxis Precision Medicines (Issuer)
Souza Marcio (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
8:48 PM | Kelly Timothy Edwin (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
8:50 PM | Mastrocola Lauren (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
8:30 PM | Mastrocola Lauren (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
8:30 PM | Nemiroff Alex (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
6:53 PM | Point72 Asset Management, L.P. (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
11/14/2024
4:50 PM | Praxis Precision Medicines (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
4:46 PM | Praxis Precision Medicines (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
2:08 PM | Cormorant Asset Management, LP (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
11/14/2024
1:32 PM | Mastrocola Lauren (Reporting)
Praxis Precision Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Altucher: Trump’s Great Gain is starting (Ad) New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Trump’s Great Gain” has officially begun.
Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he’s laying out the full gameplan in a new presentation. See Altucher’s Trump crypto prediction here |
11/14/2024
12:45 PM | Nemiroff Alex (Reporting)
Praxis Precision Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
8:23 AM | Praxis Precision Medicines (Subject)
Verition Fund Management LLC (Filed by)
| Form SC 13G/A | |
11/12/2024
12:29 PM | Capital Research Global Investors (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G | |
11/12/2024
8:35 AM | Adage Capital Management, L.P. (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
11/06/2024
6:59 AM | Praxis Precision Medicines (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
6:57 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
2:24 PM | BlackRock, Inc. (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G | |
10/15/2024
7:00 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
4:42 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G | |
09/03/2024
7:15 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
6:20 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
6:22 AM | Praxis Precision Medicines (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
